Hepsin, a type-II membrane-associated serine protease, has been implicated in cell growth and developement as well as possible initiation of blood coagulation. Here, we report on the complete nucleotide sequence, functional characterization of key structural features and the promoter of the mouse hepsin gene. The gene has a size of <17 kb, and is composed of 12, 13, or 14 exons depending on alternative intron splicings ± one in the 5
Hepsin, a serine protease, was originally found as cDNA clones isolated from a human liver cDNA library [1, 2] . Subsequent studies determined that hepsin is a type-II membrane-associated protease of <50 kDa with its carboxyl-terminal-half proteolytic subunit at the cell surface [2±4] . Hepsin is also present in subcellular organelle fractions such as nucleus and mitochondria [3] . Recently, the rat hepsin cDNA has been determined [5] . Rat hepsin is composed of 416 amino-acid residues, one residue shorter than human hepsin. Hepsin has been implicated in cell growth [6] , development [7] , and more recently in cell-surface initiation of blood coagulation [8] as well as possible prostate cancer cell function [9] . These observations strongly suggest that hepsin may play many important roles. However, homologous recombination-based gene inactivation of mouse hepsin showed that deficiency of hepsin does not result in any severe abnormal phenotypes, other than a significant increase in the level of alkaline phosphatase [10] . Unexpectedly, an observed mild hepsin-deficiency phenotype in mice may be due to the possible presence of one or more complementing systems. This situation appears similar to other reported cases where gene inactivation in mice does not necessarily agree with the phenotypic changes predicted or observed with the deficiency of such genes in humans [11±13] . As no human hepsin deficiency is known of to date, it is difficult at the present time to explain the phenotype observed in hepsin knockout animals.
In the present study, we describe the complete nucleotide structure, characteristics of key structural elements, characterization of alternative splicings and functional analyses of the promoter region of the mouse hepsin gene.
EXPERIMENTAL PROCEDURES Materials
A l FIXII mouse genomic library constructed with liver DNA from mouse (strain 129) was purchased from Stratagene. Restriction enzymes, calf intestinal alkaline phosphatase, and T 4 DNA ligase were purchased from New England Biolabs. T 4 polynucleotide kinase was obtained from United States Biochemical. Qiagen plasmid kit was purchased from Qiagen Inc. Taq polymerase, SuperScript TM II Reverse Transcriptase, SuperScript One-Step TM reverse transcription-polymerase chain reaction (RT-PCR) system, RNase H, pUC18, pBluescript, agarose, Dulbecco's modified Eagle's medium (DMEM), fetal bovine serum, and sheared herring sperm DNA were purchased from GIBCO Life Technologies. DNase I and Fugene TM 
Screening of the lFIXII genomic library
Screening of l phage genomic library was carried out by the standard method [14] . Briefly, the library was propagated in Escherichia coli XL-1-Blue MRA, and <500 000 independent phages were plated at a density of 5.0 Â 10 4 phages per 150-mm plate. Phage particles transferred to nylon filters were then screened with the human hepsin cDNA [1] labeled with 32 P to a specific activity of 1.0 Â 10 9 c.p.m.´mg 21 by employing the random priming method using a Megaprime kit (Amersham). Positive clones identified were plaque-purified and amplified on plates to obtain high-titer stocks. Large-scale preparations of recombinant phages were then carried out by the liquid culture method [15] . Phage clones containing the 5
H -end region of the mouse hepsin gene were obtained by screening the genomic library with a genomic DNA fragment (667 bp in size) corresponding to the most 5
H -end region of the insert of a phage clone mHepl61 by PCR.
DNA sequence analysis
Phage DNAs were digested with NotI, and electrophoresed on an 0.6% agarose gel. The insert DNAs were then recovered by utilizing GenecleanwII (BIO 101 Inc.), subcloned into the pBluescript vector at the NotI site, and used for subsequent restriction mapping and sequencing. Southern blot analysis of restriction fragments was carried out with either ApaI/StyI (257 bp) or Bgl II/ApaI (422 bp), which represents the 5 H -or 3 H -distal portions of the human hepsin cDNA sequence, respectively [1] . Selected restriction fragments of the inserts were subcloned into pUC18 and subjected to sequencing using Thermal Sequenase radiolabeled terminator cycle sequencing kit (Amersham). All sequences were analyzed two (once for each strand) or more times to eliminate inadvertent errors with M13 universal primers and hepsin-specific oligonucleotide primers. DNA sequences were stored and analyzed by the dnasis program (Hitachi SK) and the GCG program in the vax computer at the General Clinical Research Center of this campus.
Primer extension analysis
Primer extension analysis was carried out as previously described, with minor modifications [16] . An oligonucleotide primer (19 nucleotides in length), designed to the nucleotide sequence +77 to +95, was labeled with 32 P to a specific activity of 5. (Fig. 4A ). This primer corresponds to a sequence in exon 6 (nucleotides +11 460 to +11 483) of the mouse hepsin gene. Specific amplification of the regions containing the entire region of alternative splicings was then performed with primer a (5 H -CACCCTTGCCTTCCGGG-CTGTC-3 H , nucleotides +87 to +108 in exon 1) and primer f. Then, PCR was carried out as follows: initial incubation at 94 8C for 2 min, followed by 35 cycles of 94 8C for 30 s, 58 8C for 30 s, and 72 8C for 1 min, finishing with a 10-min extension at 72 8C. A total RNA sample treated with RNase A was included as a negative control. The resulting PCR products, a mixture of fragments of different size ranging from 300 to 900 bp, were gel-purified and used as the template for subsequent PCR with the common 5
H , nucleotides +97 to +116 in exon 1) and, either primer d (5 H -TGCAGTCCGGCCACCCTCCTTC-3 H , sequence spanning the junction of exon 2 and exon 4, nucleotides +642 to +649 and nucleotides +6067 to +6080, respectively) or primer e (5 H -TGCAGTCCGGCCACCCTTTCCA-3 H , sequence spanning the junction of exon 3 and exon 4, nucleotides +4552 to +4559 and nucleotides +6067 to +6080, respectively). PCR reamplification was also performed with primer c (5
H , nucleotides +484 to +501 in intron 1) and either primer d, e, or f. PCR products were seperated by 2% agarose gel electrophoresis. DNA fragments produced were then cloned into a pCR2.1 vector (TA cloning kit, Invitrogen). Positive identification of the cloned fragments was performed by DNA sequencing analysis.
Cell culture
HepG2 cells, a human hepatoma cell line [17±19], were used for transient expression assay as described previously [20] . Cells were grown and maintained in DMEM supplemented with 10% fetal bovine serum and antibiotics (penicillin and streptomycin) at 37 8C under 5% CO 2 in a humidified incubator. Fetal bovine serum used in HepG2 cell culture for assaying factor IX activity was pretreated with barium sulfate as previously described [21] .
Construction of expression vectors
hFIX expression vector p-416FIXm1, which has been previously described [20] , was used as the starting vector for constructing two expression vectors containing the hepsin promoter. The hepsin promoter region (nucleotides 2274 to +59) was generated by PCR with the hepsin genomic DNA as the templete, using the 5 H -and 3 H -primers with SphI and NheI linkers, respectively. The SphI/NheI fragment generated (333 bp in size) was inserted into p-416FIXm1 at SphI/NheI sites replacing hFIX promoter sequence (nucleotides 2416 to +22), thus generating p-274HSN/FIXm1, which has no 5 H -UTR intron. p-274HSNIn/FIXm1 was generated by inserting a PCR-amplified hepsin fragment (890 bp in size, spanning nucleotides 2274 to +616), which has the 5 H -UTR intron sequence, into p-416FIXm1 in a similar manner as described for the construction of p-274HSN/FIXm1. All the PCR-amplified regions and ligation sites of the expression vectors were sequenced to verify the correct sequences. Large-scale preparations of p-274HSN/FIXm1 and p-274HSNIn/FIXm1 were performed with Qiagen plasmid kit (Qiagen Inc.), and used for transient expression assays [22] . These expression vectors with the well-defined factor IX reporter gene allow efficient evaluation of promoter strength simply by determining the secreted factor IX.
Transient factor IX expression assays
Transient expression assays of p-274HSN/FIXm1 and p-274HSNIn/FIXm1 were performed as previously described [20] using HepG2 cells and Fugene TM 6 Transfection Reagent (Boehringer Mannheim). hFIX produced into the culture medium was quantified by ELISA [20] . HepG2 cells (60±70% confluency in 6-cm dishes) were cotransfected with a mixture of 8 mg of test-expression vectors and 0.8 mg of pCH110 (internal control for transfection efficiency). Sheared herring sperm DNA and p-416FIXm1 were used for transient assays as the mock and positive controls, respectively. Expression values obtained for the herring sperm DNA mock control were subtracted from those of the factor IX expression vectors. Unless otherwise indicated, all expression vectors were assayed in duplicate in four independent experiments, and averages of the results are presented.
RESULTS

Isolation and sequencing of the mouse hepsin gene
Two positive phage clones, designated as mHepl61 and mHepl11, were initially isolated from the mouse liver genomic DNA library in lFIXII (5 Â 10 5 independent phage clones) (Fig. 1A) . mHepl61 contained most of the middle portion, and mHepl11 contained the 3 H -half of the gene. By screening <3 Â 10 5 independent phages of the same library with the 5 H -portion of the insert of mHepl61 as the screening probe, the third clone mHepl3, which contains the 5 H -end region, was obtained. Inserts of these clones were subjected to sequencing analysis.
The complete contiguous nucleotide sequence for the mouse hepsin gene, which spans <17 kb, is shown in Fig. 2 . The gene consists of 12±14 exons (1±14) depending on three alternative splicings, which are responsible for generating exon 2 and/or 3. Possible exon/intron organization combinations are shown in Fig. 1B . Exon sequences accounted for 11% of the gene length. The transcription initiation site determined by primer extension analysis was at 636 bp 5
H -upstream of the first methionine codon in the 5 H -UTR [23] and was designated nucleotide +1 (Fig. 2) . Exons size ranges from 41 bp (exon 8) to 349 bp (exon 14) , and that of intron from 76 bp (intron 5) to 5417 bp (intron 2). Intron splicing junctions conform to the GT-AG rule [24, 25] . The first intron located in the 5 H -UTR is subjected to alternative splicing (Fig. 1B, 1a and 1b) . Exon 4 encoded most of the transmembrane domain. Two alternative splicings, which might take place in the second intron (Fig. 1B, 1a) , could generate an extra exon (exon 3) encoding an in-frame sequence of 20 amino-acids, DEEPGAHRGGSTCSRPQPGK (Fig. 2) , which was found in some, but not all, mouse cDNA clone [7] . Exon 5 encodes the C-terminal end region (5 amino-acid sequence) of the transmembrane domain and a stretch of 9 amino acids. Exons 6±8 encode the spacer region between the membrane spanning hydrophobic sequence and catalytic subunit. The serine protease catalytic subunit consisted of 255 amino-acid residues is encoded by six exons (exon 9±14). If the exon/intron organization is that of Fig. 1B, 2a , the predicted size of hepsin mRNA is 1806 bases, in agreement with one of the two distinct mRNA species (<1.8 kb and 1.9 kb) observed in Northern blot analysis [7] . If no alternative splicing takes place either in the 5 H -UTR or in the second intron generating exon 3 as shown in Fig. 1B, 1b , the 1.9-kb mRNA species may be generated.
Several different repetitive sequences were found in the introns and flanking regions (Fig. 2) . B1 elements of the B-type repeats [26±29] were found in intron 2 (nucleotides +5225 to +5357 in 5 H -to 3 H -orientation) and intron 4 (nucleotides +10 695 to +10 798 in 3 H -to 5 H -orientation), while B2 elements were present in intron 9 (nucleotides +13 495 to +13 679 in 5 H -to 3 H -orientation, and nucleotides +14 507 to +14 699 in 3 H -to 5 H -orientation). A polypurine tract of the structure (AGGG) 13 was located in intron 4 (nucleotides +8406 to +8457). Five and a half tandem repeats of 30-bp H (nucleotides + 1 to +649) is generated by no splicing of the first intron (intron 1), and exon 3 (nucleotides +4500 to +4559) is generated by alternative splicings in the second intron.
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Alu-like type III repetitive sequence [30] were also present in intron 4 (nucleotides +8935 to +9214). This stretch of repeat sequences has a 90% similarity to that found in murine urokinase-type plasminogen activator receptor gene [31] . These repeats may be able to form stem-loop structures. In addition to these, a stretch of dinucleotide repeats (CA) 7 TA(CA) 13 and (TG) 23 (CG) 9 , which are capable of forming left-handed Z-DNA structure [32±34], were found in intron 9 (nucleotides +13 423 to +16 464) and in the 3 H -flanking region of the gene (nucleotides +16 757 to +16 820), respectively.
Nine nucleotide sequence differences were found between the coding sequence reported in the present study and that of the mouse cDNA recently reported by Vu et al. [7] . These differences included those at nucleotides 11 423 (A), 11 429 (A), 11 435 (G), 11 450 (T), 11 622 (G), 12 211 (T), 12 506 (T), 12 531 (T), and 15 732 (C). Bases in parentheses were previously reported by Vu et al. [7] . The difference at nucleotide 11 435 causes an amino-acid change from Leu65 [7] to Phe65 in the present study. These differences may be due to sequencing errors in the reported cDNA or to mouse strain-dependent polymorphisms. The predicted amino acid sequence of the mouse hepsin showed an overall similarity of 88% or 97% with those of human [1] and rat hepsin [5] , respectively.
Transcriptional initiation site
The major transcription initiation site for the mouse hepsin gene was mapped to C at the position, 636 bp 5 H -upstream to the first Met residue codon (Fig. 3) , and was defined as nucleotide +1 in the numbering system (Fig. 2) . No such signals were observed in control lanes containing either a total RNA sample treated with RNase A or a total RNA alone (Fig. 3, lanes 1 and 2) .
Characterization of alternative splicings
Comparison of the mouse hepsin genomic sequence with those of human [1] and mouse [7] hepsin cDNAs suggested possible alternative splicings, which were responsible for generating multiple cDNA forms. This possibility was tested by a combination of RT-PCR and subsequent PCR analyses using total mouse liver RNA and pairs of specific primers (Fig. 4A) . RT-PCR amplification with a combination of primer a and primer f yielded two bands of 462 and 402 bp, and an unaccounted band of <490 bp (Fig. 4B, lane 2) . The first two bands corresponded to the products predicted for hepsin cDNA species with or without exon 3 ( Figs 1B, 1a and 2a) , respectively. This was further confirmed by DNA sequencing. Control RT-PCR performed with RNA samples treated with RNase A and the same primer set did not result in amplification products, confirming the high specificity of RT-PCR used (Fig. 4B, lane 5) . We further confirmed the existence of alternative splicings, generating 1a and 2a, by subsequent PCR using the first RT-PCR products as a template and primer b in combination with splice variant-specific primers d and e, respectively. The resulting PCR products of 105 and 165 bp (Fig. 4B, lanes 6 and 7) corresponded to hepsin isoforms 2a and 1a, respectively. 1a and 2a corresponded to hepsin isoforms with and without a 20 amino acid stretch of extra-sequence in the cytosolic side of hepsin, respectively. No RT-PCR amplification products with expected sizes of 793 and 853 bp for hepsin isoforms 2b and 1b, respectively, which should correspond to hepsin mRNA containing the 5 H -UTR intron sequence, were observed (Fig. 4B, lane 2) , indicating efficient splicing of the 5 H -UTR intron (intron 1) sequence. However, subsequent PCR amplification of the RT-PCR products (lane 2) with primer c and primer f did produce fragments of 395 and 455 bp, which were expected for the presence of the unspliced 5 H -UTR sequence, indicating that the intron 1 is mostly, but not completely spliced (Fig. 4B, lane 10) . This is in agreement with the observation that no detectable amplified products was obtained for RT-PCR using the same primer sets (Fig. 4B, lanes  3 and 4) . In lane 10, an extra band of <490 bp corresponding to the unknown band in lane 2 was also observed, suggesting that it is a byproduct of nonspecific priming of primer f. With combinations of primer c and splice variant-specific primers d or e, 2b-and 1b-specific products (181 and 241 bp, respectively) were also amplified (Fig. 4B, lanes 8 and 9) . Sequence analysis of these two products confirmed their identity with 2b and 1b, respectively. The alternative splicings in the second intron were estimated to take place in approximately half of the hepsin transcripts, accounting for the similar abundance of 1.8 and 1.9-kb mRNA species [7] . Together, all four hepsin forms (Fig. 1B) were generated from a single hepsin gene by the alternative splicings in the 5
H -UTR and the second intron, which independently take place from each other.
Promoter activity in HepG2 cells
To examine whether the 5
H -flanking sequence of the hepsin gene up to nucleotide 2274 actually has promoter activity, we generated two hepsin expression constructs (p-274HSN/FIXm1 and p-274HSNIn/FIXm1), which contain a hFIX minigene reporter gene, FIXm1, linked to the 5 H -flanking sequence with and without the 5 H -UTR intron (intron 1) sequence. p-416FIXm1, which contains the hFIX promoter linked to FIXm1, was used as a positive control [20] . HepG2 cells transfected with p-416FIXm1 (1 Â 10 6 cells) produced 50±60 ng of recombinant hFIX into the culture medium in 48 h p-274HSN/FIXm1 produced hFIX at a 22% level of that by p-416FIXm1 (Table 1 ). Inclusion of the 5 H -UTR intron sequence in the expression vector (p-274HSNIn/FIXm1) enhanced the hFIX expression level by < sevenfold over that of p-274HSN/FIXm1 (Table 1) . These results indicated that the 5 H -flanking sequence of the hepsin gene up to nucleotide 2274 has a strong promoter activity in HepG2 cells.
DISCUSSION
Hepsin was originally identified from human liver cDNA clones in 1988 [1] . Since then, several important findings have been made, strongly indicating it has potential physiological and pathophysiological roles. However, its major physiological function still remains unknown. We have determined its complete contiguous nucleotide sequence and characterized some important structural properties of the mouse hepsin gene.
The hepsin gene is <17 kb in size, and is composed of 12±14 exons depending on the combinations of the three alternative splicings (Fig. 1B and Fig. 2) . Interestingly, its transcription initiation site (nucleotide +1), which is 636 bp 5
H -upstream to the first Met codon, is in the middle of cytidine-rich region with no specific TATA box present in the neighboring areas (Fig. 2) . Several known repetitive sequences in mouse genes including B1, B2, and 5.5 units of Alu-like type III repetitive elements have been found in introns (Fig. 2) . These repeats, particularly Alu-like type III repetitive repeats, which have five potential Fig. 3 . Transcription initiation site of the mouse hepsin gene. Primer extension analysis was carried out with a radiolabeled 19-mer oligonucleotide, which is designed complementary to the sequence nucleotides +77 to +95. The reference sequence ladders were generated by sequencing reactions with the same primer and corresponding DNA template. Lane 1, primer extension products using total RNA treated with RNase A. Lane 2, same as lane 1 except no [ 32 P]-labeled primer was included. Lane 3, primer extension products generated from mouse liver total RNA. The major transcription initiation site is shown by an arrow.
q FEBS 1999 unique stem-loop structures, are of interest in relation to hepsin gene regulation, and warrants further study. The exon/intron organization pattern of the serine protease subunit belongs to the complex type similar to those of plasminogen [35] and prothrombin genes [36] , but not to those of trypsin [37] and factor IX [38] . Interestingly, an additional intron exists separating the last 12 amino acids of the C-terminal sequence into the last exon, exon 14 (Fig. 2) . The plasminogen and prothrombin genes do not have any corresponding intron in the catalytic subunits. Interestingly, however, the rat elastase gene has an equivalent intron [39] , while the overall exon/intron organizations of the hepsin and elastase genes are dissimilar to each other. The exon/intron organization pattern of the N-terminal half of hepsin, where the hydrophobic sequence is contained, is simmilar to those of membrane spanning domains of various other membrane-associated protein genes [40, 41] .
An alternative splicing takes place in the 5 H -UTR of the human hepsin transcripts as previously shown [1] (Fig. 1B,  2a,b) . For mouse hepsin cDNAs, only spliced forms of this intron have been observed to date [7] . The present studies, using combinations of RT-PCR, and subsequent PCR demonstrate that the intron in the 5 H -UTR is spliced in most, but not all of the hepsin transcripts. Two mRNA species, 1.8 kb and 1.9 kb in size, correspond to spliced and unspliced forms, respectively, resulting from the two alternative splicing sequences in the second intron [7] . Both spliced and unspliced forms are produced in the liver at almost equal amounts as estimated from the Northern blot analysis [7] , which is further supported by the present RT-PCR/PCR analyses. Importantly, two alternative splicings in the second intron generate a hepsin isoform containing a unique stretch of 20 extra residues, DEEP-GAHRGGSTCSRPQPGK, in frame in the cytosolic side. This finding establishes that the single gene is responsible for generating both forms of hepsin. This unique extra sequence is predicted to have a highly twisted, irregular secondary structure [42] . This isoform may be able to confer a distinct signal transduction, not available to hepsin without this extra sequence, thus endowing it with substantially different biological functions. This and whether the similar alternative splicings take place in tissues other than the liver have yet to be determined. As shown by RT-PCR/PCR analyses, an alternative splicing in the 5 H -UTR obviously takes place independently from the other two in the second intron (Fig. 4,A,B) .
The basal hepsin promoter region (nucleotides 2274 to +59) can confer strong expression activities, suggesting that the major structural elements required for hepsin expression are contained within this relatively small 5 H -flanking region. Elevation of the transcriptional activity (< sevenfold) in the presence of an intron when compared to levels in its absence is in agreement with the similar observations for other genes [20] . A computer search predicted several structural elements including SP1, AP2, C/EBP, LF-A1, and E box present within the promoter region (Fig. 2) , suggesting that these elements may be in part responsible for hepsin gene expression in the liver and other tissues [3] . Preliminary footprinting analyses using the liver nuclear extracts suggested apparent protein binding to the predicted SP1 site (nucleotides 260 to 242), but not to other sites (data not shown).
Hepsin has been suggested to have potential roles in developement [6, 7] , both normal and cancer, cell growth [6] , and cell-surface initiation of blood coagulation [8] . Interestingly, Table 1 . Hepsin promoter activities with the Factor IX reporter gene. Values represent mean hFIX levels^SD (n = 4). The hFIX level produced by p-416FIXm1 is defined as 100%.
Constructs
Relative factor IX level (%)
155 ^7.5 however, inactivation of the gene in mice results in an approximate twofold increase in the level of alkaline phosphatase, but gives no other obvious abnormal effects (e.g. during development) and animals are born virtually normal and survive to adulthood [10] . This may be due to a possible presence of redundant hepsin-like activities in mice. Furthermore, absence of hepsin may have detrimental effects on the ageing process or may affect pathological processes, such as cancer growth and metastasis. Indeed, Tanimoto et al. [9] recently reported an elevated hepsin expression in ovarian cancer, suggesting a potentially important role in cancer. As several lines of independent studies [3,6±9] strongly support the importance of hepsin, further vigorous studies aiming to determine its biological functions are warranted. Thus, availability of the complete nucleotide sequence and establishment of key functional characteristics of the hepsin gene will provide a dependable foundation for such studies.
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